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Abstract
Objective—Dementia is a common clinical presentation among older adults with Down 
syndrome. The presentation of dementia in Down syndrome differs compared with typical 
Alzheimer’s disease. The performance of manualised dementia criteria in the International 
Classification of Diseases (ICD)-10 and Diagnostic and Statistical Manual of Mental Disorders-
IV-Text Revision (DSM-IV-TR) is uncertain in this population.
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We aimed to determine the concurrent validity and reliability of clinicians’ diagnoses of dementia 
against ICD-10 and DSM-IV-TR diagnoses. Validity of clinical diagnoses were also explored by 
establishing the stability of diagnoses over time.
Methods—We used clinical data from memory assessments of 85 people with Down syndrome, 
of whom 64 (75.3%) had a diagnosis of dementia. The cases of dementia were presented to expert 
raters who rated the case as dementia or no dementia using ICD-10 and DSM-IV-TR criteria and 
their own clinical judgement.
Results—We found that clinician’s judgement corresponded best with clinically diagnosed cases 
of dementia, identifying 84.4% cases of clinically diagnosed dementia at the time of diagnosis. 
ICD-10 criteria identified 70.3% cases, and DSM-IV-TR criteria identified 56.3% cases at the 
time of clinically diagnosed dementia. Over time, the proportion of cases meeting ICD-10 or 
DSM-IV-TR diagnoses increased, suggesting that experienced clinicians used their clinical 
knowledge of dementia presentation in Down syndrome to diagnose the disorder at an earlier stage 
than would have been possible had they relied on the classic description contained in the 
diagnostic systems.
Conclusions—Clinical diagnosis of dementia in Down syndrome is valid and reliable and can 
be used as the standard against which new criteria such as the DSM-5 are measured.
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Introduction
Down syndrome is the most common genetic cause of intellectual disability, and dementia is 
common in adults with Down syndrome. Post-mortem studies indicate that 
neuropathological changes typical of Alzheimer’s disease are almost universal in people 
with Down syndrome over the age of 40years (Wisniewski et al., 1985; Mann et al., 1986). 
Alongside this, an earlier mean age of onset of dementia has been shown to be between 50 
and 55years in this group (Prasher and Krishnan, 1993), and data show that by the age of 
60years between 30 and 40% of people with Down syndrome will warrant a diagnosis of 
dementia (Holland et al., 1998; Tyrrell et al., 2001; Coppus et al., 2006).
There is evidence to suggest that the presentation of dementia in people with Down 
syndrome is different from typical Alzheimer’s disease. In particular, it appears that 
symptoms related to frontal lobe deterioration such as changes in personality and behaviour 
are more notable early in the course of the disease (Ball et al., 2006; Deb et al., 2007a), 
although the reasons underlying this observation are not clear.
However, the prominent behavioural and emotional changes associated with Alzheimer’s 
disease in Down syndrome may also be an artefact representing the fact that people with 
Down syndrome are not diagnosed until later in the course of the disease. There are several 
possible reasons why a diagnosis of Alzheimer’s disease may be delayed in older adults with 
Down syndrome. Firstly, there are inherent difficulties in diagnosing cognitive decline in 
those with a pre-existing cognitive impairment. Standard screening tools such as the Mini-
Sheehan et al. Page 2
Int J Geriatr Psychiatry. Author manuscript; available in PMC 2015 December 15.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Mental State Examination (Folstein et al., 1975) and other direct neuropsychological tests 
are often not appropriate because of a ‘floor effect’ (Deb et al., 2007b). Subtle cognitive 
decline may be difficult to determine, particularly in people who have not attained many 
skills and in those living in a residential setting where environmental demands are low. 
Clinicians are therefore greatly dependent on informant history. In some cases, caregivers 
might not seek intervention until later in the course of the disease when behaviour becomes 
more difficult to manage. Because of these issues, there is debate about whether the current 
manualised criteria for diagnosing dementia, namely, the International Classification of 
Diseases (ICD)-10 (World Health Organisation, 1992) and Diagnostic and Statistical 
Manual of Mental Disorder-IV-Text Revision (DSM-IV-TR) (American Psychiatric 
Association, 2000), are applicable to the dementia syndrome associated with Alzheimer’s 
disease in Down syndrome, particularly as it has been shown that employing different 
systems of classification influences the reported prevalence of dementia in people with 
intellectual disability (Strydom et al., 2007).
As life expectancy increases for people with Down syndrome (Bittles et al., 2007), dementia 
will become a more common presentation. This has implications not only for individuals 
concerned but will also demand changes in service provision and impact in terms of 
increased caregiver stress and economic cost. Early diagnosis is important so that 
symptomatic medication such as acetylcholinesterase inhibitors can be offered at a suitable 
time and psycho-social interventions, including appropriate support for carers, can be 
implemented at a time that is most beneficial.
Given the complexities in diagnosing dementia in people with Down syndrome, many 
attempts have been made to standardise the assessment process. Instruments have been 
developed (or adapted) and can be based on either informant interview or direct cognitive 
assessment (Deb and Braganza, 1999), although there seems to be lack of consensus as to 
the most appropriate (Strydom and Hassiotis, 2003). Similarly, while the physician’s clinical 
judgement has regularly been regarded as the ‘gold standard’ against which other measures 
are tested, some authors have argued that this could result in a higher number of adults being 
diagnosed (Burt et al., 2005). It is important to evaluate the validity and reliability of clinical 
diagnoses in this population while new criteria are being introduced for the DSM-5 and 
ICD-11 as it could help to establish a standard against which new criteria can be measured.
We aimed to determine the concurrent validity and reliability of clinicians’ diagnoses of 
dementia against ICD-10 and DSM-IV-TR diagnoses. Validity of clinical diagnoses was 
also explored by establishing the stability of diagnoses over time, and we also aimed to 
establish the reliability of dementia diagnoses according to ICD-10, DSM-IV-TR and 
clinician’s judgement.
Materials and method
Identification of participants and collection of data
Anonymised clinical data from adults with Down syndrome or intellectual disability were 
eligible for inclusion in the Aging with Down Syndrome or Intellectual Disability (ADSID) 
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database. This database consists of memory assessments conducted since 1996 by different 
clinicians across several sites in London and the surrounding area.
Each memory assessment included an examination of the patient’s functioning in several 
domains (cognitive ability, mood, daily living skills and social behaviours, neurological 
function and detailed mental state examination) and a comparison of how this may have 
changed from baseline levels, in accordance with published best-practice guidelines (Royal 
College of Psychiatrists and the British Psychological Society, 2009). Details of comorbid 
physical or mental health conditions were also reported. We excluded all data from adults 
who did not have Down syndrome and participants for whom insufficient data were 
available.
Data were collected retrospectively from participants’ medical records and entered into the 
ADSID database. Basic demographic information (age and gender) was obtained from the 
clinical records. The presence of Down syndrome was verified by review of the notes, 
although the method used for the original diagnosis varied. Information regarding cognitive, 
behavioural and emotional symptoms from each assessment was recorded. In addition, the 
results of screening tests (e.g. the Dementia questionnaire for people with Learning 
Disabilities (Evenhuis et al., 2006)), recent physical and mental health problems and 
physical investigations were also noted.
Ethics approval
The ADSID study was approved by the Newcastle and North Tyneside 1 Research Ethics 
Committee, and approval for collecting anonymised data from medical records was obtained 
from the National Information Governance Board. Where required, Caldicott Guardians of 
data providers gave approval for data transfer.
Concurrent validity ratings of clinical diagnoses of dementia
Clinical dementia diagnoses were defined as confirmed diagnoses of dementia recorded by 
clinicians following clinical assessment. All memory assessments were then summarised in 
anonymised case vignettes by the researchers, without making reference to clinical 
diagnosis. We also removed reference to treatment with acetylcholinesterase inhibitors and 
memantine. Case vignettes were also produced for assessments preceding and following the 
diagnosis of dementia, where available.
The case vignettes were then presented to two raters who worked independently to rate the 
case by applying diagnostic criteria delineated in ICD-10 and DSM-IV-TR; that is, the raters 
assigned the case to ‘no dementia’ or ‘dementia’ according to either ICD-10 or DSM-IV-TR 
criteria (Table 1). Use of the ICD-10 category of ‘tentative dementia’ was also included.
Raters were also asked to make a separate rating based on their clinical judgement and rate 
the cases as no dementia, ‘cognitive concern’, ‘possible dementia’ or ‘certain dementia’. 
Cognitive concern was defined as any evidence of deterioration in cognitive function but 
where this was of recent onset only and where the rater was unable to exclude a physical 
causation (such as hypothyroidism) or a mental illness causing changes in behaviour or 
memory (such as depression). Possible dementia was defined as likely dementia (i.e. 
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significant decline over 6 months or more) but where the raters felt the vignette lacked 
evidence to be certain of a diagnosis and where they would have wanted further information 
or to offer another appointment to confirm results and symptoms.
Raters were clinicians (psychiatrists and psychologists) working in the fields of Psychiatry 
of Intellectual Disability or Psychiatry of Older People who were members of a ‘dementia in 
intellectual disabilities’ special interest group. Raters remained blinded to the patient’s true 
clinical diagnosis and any treatment received.
After rating each assessment independently, the raters compared outcomes for each 
assessment. Where there was disagreement between the raters’ outcomes, a discussion 
ensued, and a consensus was achieved and recorded. For a subset of assessments, the 
outcome of each individual rater was recorded prior to consensus allowing for determination 
of inter-rater reliability.
Stability of diagnoses over time
In order to explore the stability of clinical dementia diagnoses, we compared the outcomes 
of the rater’s assessments from the time of clinical diagnosis (t) and at the first (t+1) and 
second (t+2) assessments following a clinical diagnosis. The time between subsequent 
assessments (t, t+1 and t+2) was not less than 3 months and not more than 18 months.
Clinical assessments were available in 26 out of 64 (40.6%) of cases at all three of these 
time points.
Inter-rater reliability
In order to establish inter-rater reliability, we recorded the raters’ diagnoses before they 
agreed the diagnosis in a subset of 23 cases. This was conducted on data from participants’ 
first clinical assessments. In the ICD-10 analysis, the dementia group included ratings of 
tentative dementia and dementia. In the clinical judgement analysis, ratings of dementia and 
possible dementia were included in the dementia group, and the no dementia group included 
ratings of cognitive concern and no dementia.
Analysis
Statistical Package for the Social Sciences (SPSS) version 21 was used for data entry and 
analysis. Descriptive demographics and frequencies were calculated. Inter-rater reliability 
was calculated using Cohen’s kappa for inter-rater agreement.
Results
Demographic information
The final database for this analysis comprised 85 participants with Down syndrome. Three 
quarters (75.3%) of these had a clinical diagnosis of dementia (n = 64). Twenty one 
participants (24.7%) did not have a diagnosis of dementia recorded at clinical assessment 
and were included in order to help identify accuracy of diagnoses. The participants 
comprised 40 men (47.1%) and 45 women (52.9%).
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Overall, 21 participants (24.7%) had mild (intelligence quotient (IQ) 70–50), 40 (47.1%) 
had moderate (IQ 35–50), and 12 (14.1%) had severe or profound (IQ < 35) intellectual 
disability. In 12 cases (14.1%), the level of intellectual disability was unknown.
The age range at which a clinical diagnosis of dementia was made was between 35.5 and 
70.9 years (mean ± SD = 55.4 ± 6.6 years).
Concurrent validity ratings of clinical diagnoses of dementia
At the clinical assessment at which a diagnosis of dementia was made, the raters agreed with 
the clinical diagnosis in 84.4% (n =54) of all cases (n = 64) on the basis of ‘any diagnosis’ 
of dementia (i.e. using either ICD-10, DSM-IV-TR or clinical judgement, or a combination 
of these). In 10 (15.6%) cases where a clinical diagnosis of dementia had been made, the 
raters did not make a diagnosis of dementia.
The rater’s clinical judgement showed best agreement with original clinical diagnosis—the 
raters diagnosed dementia or possible dementia in 54 (84.4%) cases at the time point when a 
clinical diagnosis was first given, and in an additional 4 (6.2%) cases the raters chose 
cognitive concern to describe the case. In only 6 (9.4%) cases of clinically diagnosed 
dementia where the raters used their clinical judgement to inform their decision, the 
outcome was of no dementia. This was followed by ICD-10; 45 (70.3%) cases met ICD-10 
criteria for dementia (28 cases, 43.8%) or tentative dementia (an additional 17 cases, 
26.6%), while DSM-IV-TR criteria diagnosed 36 (56.3%) cases of clinician-diagnosed 
dementia.
Fifty per cent (n = 32) of those with a clinical diagnosis of dementia were rated as having 
dementia by all three measures, namely, ICD-10 and DSM-IV-TR criteria and using the 
rater’s clinical judgement.
See Figure 1 for more details.
Stability of diagnoses over time
Figure 2 shows the trends in how rater’s diagnoses changed from the time of initial clinical 
diagnosis of dementia (t) and subsequent first (t+1) and second (t+2) assessment following 
this. This data are obtained from the subgroup of participants who had data for all three 
assessments (n =26).
Inter-rater reliability
In 23 of the initial assessments, the individual rater’s outcomes were recorded, in order to 
assess the inter-rater reliability of diagnoses using clinical judgement, and by application of 
standardised criteria (ICD-10 and DSM-IV-TR). This subset represented 27.1% of the 
overall sample. Cohen’s kappa was calculated as 0.911 for agreement between raters when 
ICD-10 was used, 0.704 for agreement when DSM-IV was applied and 0.826 for agreement 
between raters when clinical judgement was applied to the case. All were significant at p ≤ 
0.001.
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Discussion
Dementia diagnosis in people with Down syndrome
This study was conceived to investigate the validity and reliability of a clinical diagnosis of 
dementia in people with Down syndrome and to compare it with the performance of 
established criteria. We found that half of those with a clinical diagnosis of dementia were 
rated as having dementia by both ICD-10 and DSM-IV-TR criteria and rater’s clinical 
judgement, although the overall figure for diagnosis of dementia in participants made by any 
means was 84.4%. Rater’s clinical judgement had high levels of agreement with original 
diagnoses, but ICD-10 and DSM-IV-TR criteria fared worse, suggesting that experienced 
clinicians incorporated clinical features not included in ICD-10 and DSM-IV-TR criteria 
when making a diagnosis. Taken together with results demonstrating a high degree of inter-
rater agreement, this suggests that interpretation of the criteria is consistent between 
clinicians. However, the results suggest that ICD-10 and DSM-IV-TR criteria are likely to 
underdiagnose dementia in this population, implying that the presentation of Alzheimer’s 
disease is sufficiently different in people with Down syndrome to affect performance of 
standardised criteria in this population. Furthermore, we have shown that clinical diagnoses 
have good validity, as the criteria diagnoses ‘caught up’ with clinical diagnoses at 
subsequent assessments.
We examined the characteristics of certain cases in more detail, that is, the cases where no 
diagnosis was made by the raters under any system (n=10) and the cases that were diagnosed 
by application of clinical judgement but neither ICD-10 nor DSM-IV-TR criteria (n=5). In 
the clinically diagnosed cases that were not deemed to have dementia by the raters, there 
were several people with comorbid mental and/or physical illness, suggesting that raters 
applied caution when other explanations for the decline could be relevant. In other cases, the 
decline was only recent, and in a small number of cases there was only limited information, 
which may have been insufficient for the raters to confidently diagnose.
In the cases that received a diagnosis when clinical judgement was applied but not when 
ICD-10 or DSM-IV-TR criteria were used, the decline tended to be only over a short 
duration, which may have precluded diagnosis under the stipulation that symptoms be 
present for at least 6 months (ICD-10).
As understanding and treatments advance, timely diagnosis of dementia is important to 
ensure access to interventions that improve functioning and quality of life. A diagnosis of 
dementia may be necessary for identifying and meeting changing needs in accommodation 
and nursing and social support. It is also important to facilitate adequate explanation of the 
diagnosis and prognosis for patients and relatives.
At the memory assessments following the diagnosis (t+1, and t+2), a firm diagnosis of 
dementia was made in progressively increasing proportions of cases. We therefore suggest 
that clinical judgement should be the preferred means of diagnosing dementia in people with 
Down syndrome following comprehensive assessment by clinicians who are experienced in 
recognising the symptoms of dementia in this population. Further work is required to define 
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how standard criteria need to be adapted or interpreted in this population to enable valid and 
early diagnosis of dementia.
With regards to the performance of DSM-IV-TR criteria against ICD-10 criteria, we found 
DSM-IV-TR criteria to be the most exclusive, although if the ICD category of tentative 
dementia is excluded, the ICD criteria become the most exclusive and identify less than half 
(43.8%) of those clinically diagnosed cases. It has been suggested that ICD-10 criteria are 
specific and more demanding to apply as they rely on informant information to a greater 
extent (Henderson et al., 1994).
Inter-rater reliability
We found inter-rater agreement to be strong when both operationalised criteria were applied 
by raters. This is to be expected as the DSM-IV-TR and ICD-10 criteria for diagnosis are 
formed of clear statements that have been designed specifically to reduce ambiguity and 
allow a common language between professionals. However, agreement between raters when 
clinical judgement was applied to the cases was equally as strong. We had anticipated a 
greater degree of subjectivity in appraising and interpreting the details of the vignettes to be 
reflected in lower inter-rater agreement for clinical judgement, but this was not the case.
Because of the relatively small numbers in this subset, we were not able to compare 
outcomes of the ratings given by different professional groups (i.e. psychiatrists and 
psychologists).
Implications of the study
We have shown that clinical diagnoses of dementia by experienced clinicians appeared to be 
accurate and tended to identify dementia cases earlier than operationalised criteria in older 
adults with Down syndrome, although this may still be at a later stage than dementia 
diagnoses in an equivalent population without intellectual disability. We also identified a 
discrepancy in the diagnosis of dementia amongst a population with Down syndrome, 
depending on which criteria are used to identify the illness. Following the recent publication 
of DSM-5 and an updated ICD due in 2015, now is a timely juncture to explore the way in 
which clinicians diagnose dementia in people with Down syndrome. Changes to the defined 
criteria or the way it is interpreted in this population may be necessary in order to reflect the 
differing presentation of dementia in people with Down syndrome. Our results imply that 
clinical diagnoses should be used as the yardstick against which new criteria are measured. 
Use of the Diagnostic Criteria for psychiatric disorders for use with adults with Learning 
Disability (DC-LD) (Royal College of Psychiatrists, 2001) or Diagnostic Manual - 
Intellectual Disability (DM-ID) (Fletcher et al., 2007) as alternative diagnostic systems for 
people with intellectual disability is not widespread, and research evidence relating to these 
classifications is limited. They may be less suitable for adults with mild intellectual 
disability.
Our findings also have implications for research in dementia in Down syndrome, for 
example, to estimate the prevalence and estimates of dementia or to identify potential 
participants for clinical trials of treatments for dementia in this population.
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Strengths and limitations of the study
The study has several strengths. It uses clinical data derived from memory assessments 
conducted over a wide time period from both urban and suburban locations. A range of 
people with Down syndrome between the ages of 35 and 70years with differing baseline 
levels of cognitive impairment and adaptive function were included. Our data are therefore 
fairly representative of clinical practice in the UK. Furthermore, in order to reduce bias, 
raters were blinded to the outcome of the clinical assessment and rated each case 
individually before reaching a consensus opinion.
Data from clinical assessments were transcribed onto anonymised data collection forms. 
Whilst every attempt to capture relevant information was made in both the design and 
completion of these forms, it is inevitable that some detail was lost and subtleties of clinical 
assessment that would be apparent to the treating clinician were not always available to our 
raters. Data were also dependent on the thoroughness and documentation of the clinical 
records. In addition, raters did not have the privilege of prior knowledge of the patient, as 
would often be the case in clinical practice. For these reasons, raters may have been less 
likely to make a diagnosis of dementia than their counterparts in the clinic.
In this study, we did not categorise the severity of dementia, although as the ratings were 
completed for the assessment at which a clinical diagnosis of dementia was made, it is most 
likely that the majority of new cases of dementia were in the early stage.
Conclusion
This study shows that when making a diagnosis of dementia in people with Down syndrome, 
clinicians who are experienced in assessing this population for cognitive decline are able to 
make accurate diagnoses at a relatively early stage of the disease. Clinical diagnoses were 
more inclusive than using ICD-10 or DSM-IV-TR criteria, suggesting that clinicians relied 
on dementia symptoms that are specific to this population. It remains to be seen whether 
new definitions of dementia in ICD-11 and DSM-5 will perform better in this population. 
We recommend that clinical diagnoses (following a comprehensive assessment including 
history, examination and consideration of investigations and formal cognitive assessments) 
are used as the standard against which new criteria can be judged. Further work may be 
required to establish how new criteria need to be adjusted in order to improve diagnosis in 
this population.
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Key points
• We investigated the validity of dementia diagnoses in people with Down 
syndrome.
• Application of DSM-IV-TR and ICD-10 criteria excluded some people with 
dementia.
• Clinician’s judgement diagnosed dementia at an earlier stage.
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Figure 1. 
Diagram showing outcome of ratings at the time when the clinical diagnosis of dementia 
was made (not to scale).
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Figure 2. 
Stability of diagnoses over time showing ratings at time of clinician’s diagnosis of dementia 
(t) and first (t + 1) and second (t + 2) assessments following clinician’s diagnosis of 
dementia (n = 26).
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Table 1
Summary of ICD-10 and DSM-IV-TR diagnostic criteria for Alzheimer’s dementia
Criterion ICD-10 DSM-IV-TR
Memory impairment X X
Disturbance in higher cortical functiona
Executive functioning X X
Aphasia X
Apraxia X
Agnosia X
Decline in behavioural or emotional function
Emotional lability X
Irritability X
Apathy X
Coarsening of social behaviour X
Deficits cause significant impairment in functioning X
Gradual onset and progression X
Duration at least 6 months X
Exclusions
Delirium X X
Other CNS, systemic or substance-induced conditions X X
Other mental illness X
aOnly one of these symptoms need be present for DSM-IV-TR diagnosis
Int J Geriatr Psychiatry. Author manuscript; available in PMC 2015 December 15.
